Jersey has become the second part of the British Isles to approve a law allowing assisted dying, joining the Isle of Man in permitting terminally ill adults to end their lives. The move comes as the UK continues to debate the issue, with a bill in England and Wales making slow progress in the House of Lords.
The law, which was approved by Jersey's parliament, the States Assembly, will allow terminally ill adults with mental capacity to have an assisted death if they are expected to die within six months, or 12 months if they have a neurological condition like motor neurone disease. This timeframe differs from what is being proposed at Westminster and Holyrood, where the limit would be set at six months.
Assisted dying campaigners celebrated the decision outside the States Chamber in Jersey, marking a significant milestone in the island's 800-year history of self-governance. The law is expected to come into effect next summer, pending Royal Assent in the UK.
Meanwhile, in England and Wales, a similar bill remains blocked, with opponents citing concerns about the potential for abuse and the impact on vulnerable individuals. The issue has sparked intense debate, with some arguing that assisted dying is a necessary option for those suffering from terminal illnesses, while others believe it undermines the value of human life.
As the UK grapples with the issue, a separate crisis is unfolding on the streets of England, where record levels of rough sleepers have been reported. According to the latest figures, 4,793 people were estimated to be sleeping rough on a single night last autumn, a 3% increase from the previous year. The number of female rough sleepers rose by 8% to 733, while there were 3,938 men and another 122 cases where the gender was not recorded.
The government has pledged £50m in funding to councils and frontline homelessness services, but critics argue that more needs to be done to address the root causes of homelessness. In Leeds, the Homeless Street Angels charity has been providing food, shoes, sleeping bags, and blankets to rough sleepers for the past seven years.
In other health news, Xenon Pharmaceuticals is developing a drug for the most common type of seizure experienced by people with epilepsy. The company's study is expected to read out soon, offering hope to those affected by the condition.
As the UK navigates these complex issues, it remains to be seen how the debate on assisted dying will unfold. While Jersey's decision marks a significant step forward, the road ahead is likely to be long and contentious.